The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies—reply
Adriana Albini, Douglas M. Noonan, Giuseppe Pelosi, Giovanni Di Guardo, Michele Lombardo
Topics & Concepts
MedicineAngiotensin Receptor BlockersPharmacologyAngiotensin receptorCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorACE inhibitor2019-20 coronavirus outbreakRenin–angiotensin systemAngiotensin IIAngiotensin-converting enzymeInternal medicineVirologyBlood pressureDiseaseOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 Research